These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11282095)

  • 1. Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis.
    Burnett JR; Moses EA; Croft KD; Brown AJ; Grainger K; Vasikaran SD; Leitersdorf E; Watts GF
    Clin Chim Acta; 2001 Apr; 306(1-2):63-9. PubMed ID: 11282095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology of cerebrotendinous xanthomatosis].
    Koyama S; Kato T
    Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.
    Nie S; Chen G; Cao X; Zhang Y
    Orphanet J Rare Dis; 2014 Nov; 9():179. PubMed ID: 25424010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
    DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
    J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
    Siman-Tov T; Meiner V; Gadoth N
    J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.
    Koyama S; Sekijima Y; Ogura M; Hori M; Matsuki K; Miida T; Harada-Shiba M
    J Atheroscler Thromb; 2021 Sep; 28(9):905-925. PubMed ID: 33967188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis.
    Dotti MT; Lütjohann D; von Bergmann K; Federico A
    Neurol Sci; 2004 Oct; 25(4):185-91. PubMed ID: 15549503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
    Moghadasian MH
    Clin Invest Med; 2004 Feb; 27(1):42-50. PubMed ID: 15061585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
    Takahashi M; Okazaki H; Tada H; Ishibashi S
    J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R; Grau AJ; Schäbitz WR; Schwaninger M
    Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment.
    Alhariri A; Hamilton K; Oza V; Cordoro K; Sobreira NL; Malloy M; Slavotinek A
    Am J Med Genet A; 2017 Aug; 173(8):2275-2279. PubMed ID: 28590052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
    Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
    Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebrotendinous xanthomatosis: physiopathology, clinical manifestations and genetics].
    Preiss Y; Santos JL; Smalley SV; Maiz A
    Rev Med Chil; 2014 May; 142(5):616-22. PubMed ID: 25427019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes.
    Appadurai V; DeBarber A; Chiang PW; Patel SB; Steiner RD; Tyler C; Bonnen PE
    Mol Genet Metab; 2015 Dec; 116(4):298-304. PubMed ID: 26643207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis].
    Pilo de la Fuente B; Sobrido MJ; Girós M; Pozo L; Lustres M; Barrero F; Macarrón J; Díaz M; Jiménez-Escrig A
    Neurologia; 2011 Sep; 26(7):397-404. PubMed ID: 21345536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrotendinous xanthomatosis].
    Berginer VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):13-22. PubMed ID: 1333699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis.
    Duell PB; Salen G; Eichler FS; DeBarber AE; Connor SL; Casaday L; Jayadev S; Kisanuki Y; Lekprasert P; Malloy MJ; Ramdhani RA; Ziajka PE; Quinn JF; Su KG; Geller AS; Diffenderfer MR; Schaefer EJ
    J Clin Lipidol; 2018; 12(5):1169-1178. PubMed ID: 30017468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrotendinous xanthomatosis: need for early diagnosis.
    Muhammed K; Nandakumar G; Saritha S
    Indian J Dermatol Venereol Leprol; 2006; 72(5):364-6. PubMed ID: 17050932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrotendinous xanthomatosis associated with immune thrombocytopenia.
    El Husseiny NM
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.